BioNanoSim (BNS) has developed a proprietary technology platform for the nano-encapsulation of drugs to improve delivery profile and therapeutic performance.Research conducted by Professor Simon Benita and his team has demonstrated the potential of BNS's nano-encapsulation technology to design innovative routes of administration across a range of therapeutic areas including oncology, ophthalmology, and metabolic diseases.

In addition, BNS is using its nano-encapsulation technologies to develop topical and ocular cannabis-based products.